Cyanotech Corp financial data

Symbol
CYAN on OTC
Industry
Medicinal Chemicals & Botanical Products
Location
73 4460 Queen Kaahumanu Hwy, Suite 102, Kailua Kona, HI
State of incorporation
NV
Fiscal year end
March 31
Latest financial report
10-Q - Q4 2024 - Feb 11, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 109 % -28%
Quick Ratio 76.4 % -34.5%
Debt-to-equity 134 % +46.2%
Return On Equity -44.7 % -44.4%
Return On Assets -19.1 % -18.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 7.16M shares +3.91%
Common Stock, Shares, Outstanding 7.16M shares +3.91%
Entity Public Float 3.33M USD -59.1%
Common Stock, Value, Issued 143K USD +3.62%
Weighted Average Number of Shares Outstanding, Basic 7.16M shares +9.19%
Weighted Average Number of Shares Outstanding, Diluted 7M shares +10%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 23.9M USD +6.19%
Research and Development Expense 508K USD -31.4%
Selling and Marketing Expense 4.66M USD -14.4%
General and Administrative Expense 4.61M USD +4.44%
Operating Income (Loss) -3.97M USD -0.66%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -4.65M USD -0.98%
Income Tax Expense (Benefit) 5K USD -44.4%
Net Income (Loss) Attributable to Parent -4.66M USD -0.89%
Earnings Per Share, Basic -0.66 USD/shares +9.59%
Earnings Per Share, Diluted -0.79 USD/shares -17.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 359K USD -45.7%
Accounts Receivable, after Allowance for Credit Loss, Current 1.91M USD -6.29%
Inventory, Net 7.75M USD -15%
Assets, Current 10.6M USD -14.1%
Property, Plant and Equipment, Net 9.26M USD -11.3%
Operating Lease, Right-of-Use Asset 4.03M USD -8.55%
Other Assets, Noncurrent 117K USD -7.14%
Assets 24M USD -12.1%
Accounts Payable, Current 2.15M USD +54.9%
Accrued Liabilities, Current 593K USD -21.2%
Contract with Customer, Liability, Current 65K USD -7.14%
Liabilities, Current 9.95M USD +16.5%
Operating Lease, Liability, Noncurrent 3.51M USD -9.68%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 14.5M USD +7.71%
Retained Earnings (Accumulated Deficit) -25.5M USD -22.4%
Stockholders' Equity Attributable to Parent 9.5M USD -31.3%
Liabilities and Equity 24M USD -12.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 243K USD
Net Cash Provided by (Used in) Financing Activities -183K USD -144%
Net Cash Provided by (Used in) Investing Activities -47K USD +68.7%
Common Stock, Shares Authorized 50M shares 0%
Common Stock, Shares, Issued 7.16M shares +3.91%
Common Stock, Par or Stated Value Per Share 0.02 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 13K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 974K USD -62.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 164K USD +8.61%
Deferred Tax Assets, Valuation Allowance 4.39M USD +47%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure
Deferred Tax Assets, Gross 6.51M USD +20.5%
Operating Lease, Liability 4.05M USD -7.91%
Lessee, Operating Lease, Liability, to be Paid 5.5M USD -9.35%
Property, Plant and Equipment, Gross 37.4M USD +0.22%
Operating Lease, Liability, Current 545K USD +5.42%
Lessee, Operating Lease, Liability, to be Paid, Year Two 803K USD -0.25%
Lessee, Operating Lease, Liability, to be Paid, Year One 823K USD +303%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.44M USD -13.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 456K USD -42.6%
Deferred Tax Assets, Operating Loss Carryforwards 4.47M USD +25.2%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 376K USD -51.5%
Additional Paid in Capital 34.8M USD +0.92%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 1.5M USD -7.05%
Deferred Tax Assets, Net of Valuation Allowance 2.11M USD -12.4%
Interest Expense 683K USD +2.86%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%